173 related articles for article (PubMed ID: 22122393)
21. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
22. Single agent vinorelbine as first-line chemotherapy in elderly patients with advanced breast cancer.
Rossi A; Gridelli C; Gebbia V; Rosati G; Tortoriello A; Maione P; Borsellino N; Rossi N; Pisano A; Colantuoni G; Iaffaioli RV; Castaldo V; Manzione L
Anticancer Res; 2003; 23(2C):1657-64. PubMed ID: 12820437
[TBL] [Abstract][Full Text] [Related]
23. Vinorelbine-associated myelopathy in a patient who previously received paclitaxel: a case report.
Han JY; Choi BG; Song DH; Ahn JG; Yoon JS; Lee KS
Med Oncol; 2001; 18(1):95-7. PubMed ID: 11778975
[TBL] [Abstract][Full Text] [Related]
24. Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials.
Lapeyre-Mestre M; Gregoire N; Bugat R; Montastruc JL
Fundam Clin Pharmacol; 2004 Feb; 18(1):97-105. PubMed ID: 14748761
[TBL] [Abstract][Full Text] [Related]
25. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.
Menéndez JA; Ropero S; del Barbacid MM; Montero S; Solanas M; Escrich E; Cortés-Funes H; Colomer R
Breast Cancer Res Treat; 2002 Apr; 72(3):203-19. PubMed ID: 12058962
[TBL] [Abstract][Full Text] [Related]
27. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.
Tassone P; Blotta S; Palmieri C; Masciari S; Quaresima B; Montagna M; D'Andrea E; Eramo OP; Migale L; Costanzo F; Tagliaferri P; Venuta S
Int J Oncol; 2005 May; 26(5):1257-63. PubMed ID: 15809716
[TBL] [Abstract][Full Text] [Related]
28. Vinorelbine-induced neurotoxicity in patients with advanced breast cancer pretreated with paclitaxel--a phase II study.
Fazeny B; Zifko U; Meryn S; Huber H; Grisold W; Dittrich C
Cancer Chemother Pharmacol; 1996; 39(1-2):150-6. PubMed ID: 8995513
[TBL] [Abstract][Full Text] [Related]
29. Vinorelbine: a novel vinca alkaloid.
Toso C; Lindley C
Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
[TBL] [Abstract][Full Text] [Related]
30. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
31. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Krikorian A; Breillout F
Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
[TBL] [Abstract][Full Text] [Related]
32. [Navelbine (vinorelbine): a review of its antitumor activity and toxicity in clinical studies].
Niitani H
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1495-507. PubMed ID: 10500542
[TBL] [Abstract][Full Text] [Related]
33. [A trial with single-agent vinorelbine in taxane-resistant non-small cell lung cancer].
Miyata J; Sano T; Bando H
Gan To Kagaku Ryoho; 2001 Feb; 28(2):239-42. PubMed ID: 11242654
[TBL] [Abstract][Full Text] [Related]
34. Acute respiratory failure caused by vinorelbine tartrate in a patient with non-small cell lung cancer.
Uoshima N; Yoshioka K; Tegoshi H; Wada S; Fujiwara Y; Satake N; Kasamatsu Y; Yokoho S
Intern Med; 2001 Aug; 40(8):779-82. PubMed ID: 11518124
[TBL] [Abstract][Full Text] [Related]
35. Vinflunine, a second generation novel Vinca Alkaloid with a distinctive pharmacological profile, now in clinical development and prospects for future mitotic blockers.
Hill BT
Curr Pharm Des; 2001 Sep; 7(13):1199-212. PubMed ID: 11472262
[TBL] [Abstract][Full Text] [Related]
36. An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.
Chiu WH; Su WC; Li CL; Chen CL; Lin CF
Oncotarget; 2015 Aug; 6(24):20513-24. PubMed ID: 26001295
[TBL] [Abstract][Full Text] [Related]
37. Inhibiting glucosylceramide synthase facilitates the radiosensitizing effects of vinorelbine in lung adenocarcinoma cells.
Chiu WH; Chen HH; Chang JY; Luo SJ; Li CL; Chen CL; Su WC; Lin CF
Cancer Lett; 2014 Jul; 349(2):144-51. PubMed ID: 24735752
[TBL] [Abstract][Full Text] [Related]
38. Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
Wang RC; Chen X; Parissenti AM; Joy AA; Tuszynski J; Brindley DN; Wang Z
PLoS One; 2017; 12(8):e0182400. PubMed ID: 28787019
[TBL] [Abstract][Full Text] [Related]
39. Exposure to vinorelbine inhibits in vitro proliferation and invasiveness of transitional cell bladder carcinoma.
Bonfil RD; Russo DM; Schmilovich AJ
J Urol; 1996 Aug; 156(2 Pt 1):517-21. PubMed ID: 8683728
[TBL] [Abstract][Full Text] [Related]
40. Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells.
Chiu WH; Luo SJ; Chen CL; Cheng JH; Hsieh CY; Wang CY; Huang WC; Su WC; Lin CF
Biochem Pharmacol; 2012 May; 83(9):1159-71. PubMed ID: 22285910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
